首页/数据集/TECTAL GLIOMA VERSUS PILOCYTIC ASTROCYTOMA: REVISITING TUMOR CLASSIFICATION IN LIGHT OF MOLECULAR HETEROGENEITY

TECTAL GLIOMA VERSUS PILOCYTIC ASTROCYTOMA: REVISITING TUMOR CLASSIFICATION IN LIGHT OF MOLECULAR HETEROGENEITY

ChEBI2026-08-19 更新2026-08-25 收录

肿瘤分子分型

顶盖胶质瘤鉴别诊断

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-MTAB-17457 数据链接链接失效反馈

官方服务：

资源简介：

TECTAL GLIOMA VERSUS PILOCYTIC ASTROCYTOMA: REVISITING TUMOR CLASSIFICATION IN LIGHT OF MOLECULAR HETEROGENEITY

应用场景：

创建时间：

2026-08-19

肿瘤分子分型

精准肿瘤学

Oncogenic KRAS mutations are absent in approximately 10% of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) and may represent a subgroup of mPDAC with therapeutic options beyond stan

NIAID Data Ecosystem60

sj-xlsx-4-pdp-10.1177_10935266231204788 – Supplemental material for Molecular Profiling of a Hepatocellular Neoplasm Not Otherwise Specified (HCN-NOS) Demonstrates Distinct Molecular Features in Hepatoblastoma and HCC-Like Components

肿瘤分子分型

肿瘤病理学

Supplemental material, sj-xlsx-4-pdp-10.1177_10935266231204788 for Molecular Profiling of a Hepatocellular Neoplasm Not Otherwise Specified (HCN-NOS) Demonstrates Distinct Molecular Features in Hepato

DataCite Commons2024-08-28 更新50

Summary of the properties of the basal-like prognostic biomarkers.

癌症预后生物标志物

肿瘤分子分型

Summary of the properties of the basal-like prognostic biomarkers.

Figshare2022-02-15 更新40

Identification of novel molecular subgroups in esophageal adenocarcinoma to predict response to neo-adjuvant therapies

肿瘤分子分型

治疗反应预测

Esophageal adenocarcinoma (EAC) is a highly aggressive cancer and its response to chemo-, and radiotherapy is unpredictable. EAC are highly heterogeneous at the molecular level. The aim of this study

NIAID Data Ecosystem50

Transcription profiling of human grade II astrocytic tumor (astrocytomas) vs grade IV tumors (glioblastoma)

肿瘤转录组学

肿瘤分子分型

Transcription profiling of human grade II astrocytic tumor (astrocytomas) vs grade IV tumors (glioblastoma)

ChEBI2007-03-01 更新40